These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14739102)

  • 1. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.
    Kim H; Park C; Han KH; Choi J; Kim YB; Kim JK; Park YN
    J Hepatol; 2004 Feb; 40(2):298-304. PubMed ID: 14739102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
    Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
    Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.
    Park HS; Bae JS; Jang KY; Lee JH; Yu HC; Jung JH; Cho BH; Chung MJ; Moon WS
    J Korean Med Sci; 2011 Aug; 26(8):1023-30. PubMed ID: 21860552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
    Shibuya M; Kondo F; Sano K; Takada T; Asano T
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
    Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
    Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
    Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
    Xu J; Zhang C; Qiao A; Xi Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
    Tickoo SK; Zee SY; Obiekwe S; Xiao H; Koea J; Robiou C; Blumgart LH; Jarnagin W; Ladanyi M; Klimstra DS
    Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation.
    Kumagai A; Kondo F; Sano K; Inoue M; Fujii T; Hashimoto M; Watanabe M; Soejima Y; Ishida T; Tokairin T; Saito K; Sasajima Y; Takahashi Y; Uozaki H; Fukusato T
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):414-21. PubMed ID: 27161394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
    Akiba J; Nakashima O; Hattori S; Naito Y; Kusano H; Kondo R; Nakayama M; Tanikawa K; Todoroki K; Umeno Y; Nakamura K; Sanada S; Yamaguchi R; Ogasawara S; Yano H
    J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
    Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which stem cells for adult liver?].
    Guettier C
    Ann Pathol; 2005 Feb; 25(1):33-44. PubMed ID: 15981930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic progenitor cells in human liver tumor development.
    Libbrecht L
    World J Gastroenterol; 2006 Oct; 12(39):6261-5. PubMed ID: 17072946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
    Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
    Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
    Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
    Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
    Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
    Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathological study on combined hepatocellular and cholangiocarcinoma.
    Taguchi J; Nakashima O; Tanaka M; Hisaka T; Takazawa T; Kojiro M
    J Gastroenterol Hepatol; 1996 Aug; 11(8):758-64. PubMed ID: 8872774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic progenitor cells in liver cancers from Asian children.
    Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
    Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary liver cancer with bidirectional differentiation into hepatocytes and biliary epithelium.
    Maeda A; Ebata T; Matsunaga K; Kanemoto H; Bando E; Yamaguchi S; Furukawa H; Uesaka K
    J Hepatobiliary Pancreat Surg; 2005; 12(6):484-7. PubMed ID: 16365824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.